IBSA USA

IBSA USA, operating as IBSA Pharma Inc., is the United States subsidiary of the Swiss-based IBSA Group (Institut Biochimique SA). The company specializes in developing and commercializing high-quality pharmaceutical products across several therapeutic areas, most notably endocrinology and pain management. Its flagship products in the U.S. market include Tirosint and Tirosint-SOL for the treatment of hypothyroidism, as well as the Flector and Licart topical diclofenac patches for acute and chronic pain. IBSA is recognized for its proprietary drug delivery technologies, such as PearlTec and Hydrogel, which enhance the bioavailability and patient experience of existing molecules. The company maintains a strong focus on niche markets where its specialized formulations provide distinct clinical advantages.